R. Pérez-Carrión - Concepedia

Author

R. Pérez-Carrión

Also Known As

Perez-Carrión, R., R Perez-Carrion, R Pérez-Carrión, R Pérez-Carrión, R. Perez-Carrion, R. Perez-Carrión, R. Peréz-Carrion, R. Pérez-Carrión, Ramon Perez-Carrion, Ramon Pérez-Carrión

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de La Princesa Hospital Clínico Universitario Lozano Blesa Hospital General Universitario De Valencia Hospital Universitario La Paz Hospital Arnau de Vilanova

About

R. Pérez-Carrión is an author at Hospital Universitario de La Princesa specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	227
2	Pharmacology	6	6	176
3	Health Sciences	2	2	111
4	Pathology	2	2	53
5	Obstetrics	1	1	13

R. Pérez-Carrión

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, Journal of Clinical Oncology	2001	1K
Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer Alberto Sobrero, Stephen P. Ackland, Stephen Clarke, Oncology	2009	118
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study Laura Frías, Mariano Provencio, R. Pérez-Carrión, Clinical & Translational Oncology InflammationPilot StudyBreast OncologyOncologyHealth Sciences	2018	98
Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study Cesar Pico, Miguel Martín, Carlos Jara, Annals of Oncology	2003	84
MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients Angelo Gámez‐Pozo, Luis Antón-Aparicio, Cristina Bayona, Neoplasia	2012	71
Superiority of Letrozole to Tamoxifen in the First-Line Treatment of Advanced Breast Cancer: Evidence from Metastatic Subgroups and a Test of Functional Ability Henning T. Mouridsen, Yuxiu Sun, M. Gershanovich, The Oncologist	2004	45
Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer Jaime Feliú, Antonieta Salud, María José Safont, PLoS ONE	2015	44
First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study Jaime Feliú, Antonieta Salud, María José Safont, British Journal of Cancer	2014	32
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies Teresa Morán, Jia Wei, Manuel Cobo, Annals of Oncology OncologyMedicinePathologyBrca1-rap80 Expression CustomizationBiomarker-directed Randomized Trials	2014	30
A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Juan Bayo-Calero, José Mayordomo, Pedro Sánchez‐Rovira, Clinical Breast Cancer Breast OncologyMedicinePharmacologyPathologyPhase Ii Study	2008	23

Page 1